-
Flo Rida's JettSet1 Teams Up With Biom To Bring Cannabinoid-Derived, Therapeutic Agent To Treat 'Angelman Syndrome'
Tuesday, June 20, 2023 - 10:12am | 262JettSet1 Enterprises (co-founders Erik Hicks, George Tabi, M.D., and Tramar Dillard professionally known as Flo Rida) has partnered with Biom Therapeutics (co-founders Bobban Subhadra, Ph.D, John Allen, and Paul Carney, M.D.). Biom Therapeutics is a preclinical-stage company which has an initial...
-
Psychiatrist: Why Some Enjoy Smoking Weed While Others Feel Anxious? Does Frequent Use Change Personality?
Monday, April 10, 2023 - 11:16am | 685Did you ever wonder why cannabis doesn’t affect everyone the same way? Why do some people experience pleasure and relaxation when smoking pot and others get anxious or even paranoid? To understand the various effects the same plant has on the same species, we humans that is, it’s...
-
Goodness Growth Q4 Revenue Grows 10.5% To $13.7M, Withdraws Outlook Due To Pending Acquisition By Verano
Friday, March 11, 2022 - 9:55am | 525Goodness Growth Holdings, Inc. (CSE:GDNS) (OTCQX: GDNSF) reported Friday financial results for its fourth quarter and full year ended December 31, 2021. "Our fourth quarter results reflected continued growth across most of our markets, but we continued to experience the negative impact...
-
FDA Will Foster Development Of Non-Addictive Alternatives To Opioids For Pain: Should Cannabis Be On The List?
Wednesday, February 9, 2022 - 5:59pm | 562The U.S. Food and Drug Administration (FDA) announced Wednesday that it is taking steps aimed to foster the development of non-addictive alternatives to opioids to manage acute pain and prevent new addiction. The agency issued draft guidance to provide recommendations to companies...
-
Why Cardiff Oncology Shares Are Falling
Wednesday, January 19, 2022 - 4:48pm | 208Cardiff Oncology Inc (NASDAQ: CRDF) shares are trading lower after the company announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab. "As we have increased the number of patients evaluated and the duration of follow-up,...
-
Why Nuvation Bio Shares Are Rising
Monday, December 13, 2021 - 1:01pm | 136Nuvation Bio Inc (NYSE: NUVB) shares are trading higher after the company announced FDA clearance of its investigational new drug application for NUV-422. "FDA clearance of our third IND application for NUV-422 is another important achievement for our lead investigational CDK 2/4/6 inhibitor...
-
House Committee Holds Hearing On 'Cannabis Policies for the New Decade'
Thursday, January 16, 2020 - 8:51am | 520On Wednesday, members of the House Energy and Commerce Subcommittee on Health held a hearing titled “Cannabis Policies for the New Decade." In the committee’s first ever hearing on marijuana reform, members of the House listened to the testimony of three witnesses: Matthew J....